Eosinophil and eosinophil-derived novel leukocyte ratios are strong predictors of the severity of acute coronary syndrome patients

This retrospective study of 1,053 acute coronary syndrome patients demonstrates that eosinophil levels and novel eosinophil-derived leukocyte ratios, particularly SIII and SV, are strong predictors of disease severity comparable to established markers, highlighting their potential value for rapid risk stratification in emergency settings.

The Gist

Imagine your body is a bustling city, and your heart is the central power plant. When a heart attack (Acute Coronary Syndrome or ACS) happens, it's like a major pipeline burst in that power plant. The city goes into emergency mode, sending out various "repair crews" and "security teams" to handle the damage.

This paper is like a detective story where researchers looked at the ID badges of these emergency crews (white blood cells) to see if they could predict how bad the disaster was, just by looking at a simple blood test.

Here is the breakdown of their findings using simple analogies:

1. The Usual Suspects (The Old Guard)

For a long time, doctors have looked at three specific types of cells to gauge how serious a heart attack is:

• Neutrophils (The Firefighters): They rush in first to put out the fire (inflammation).
• Monocytes (The Heavy Machinery): They come in to clean up the debris.
• Lymphocytes (The Peacekeepers): They usually help calm things down and regulate the response.

Doctors already knew that if you have a lot of Firefighters and Heavy Machinery, but very few Peacekeepers, the situation is dire. They use a "score" called NLR (Firefighters vs. Peacekeepers) to guess the severity.

2. The New Clue: The "Eosinophils" (The Rare Specialists)

The researchers decided to look at a fourth, much rarer crew member: Eosinophils.

• The Analogy: Think of Eosinophils as the city's specialized "healing architects." They are rare (less than 5% of the total crew), but they are crucial for actually fixing the damage and stopping the inflammation from getting out of control.

What they found:
In patients with severe heart attacks, the number of these "healing architects" in the blood dropped significantly. It's as if the architects were all pulled into the disaster zone to work, leaving the blood supply empty.

• Severe Heart Attack: Very few architects left in the blood.
• Mild Heart Attack: More architects still circulating.

3. The New "Super-Scores" (The Ratios)

Since the "architects" (Eosinophils) were disappearing when things got bad, the researchers created new math formulas (ratios) to measure the chaos. Instead of just counting the Firefighters, they started comparing the Firefighters to the missing Architects.

They invented new scores like SIII and SV.

• The Analogy: Imagine you are trying to judge how bad a fire is.
  • Old Way: Count how many firefighters are running around.
  • New Way: Count how many firefighters are running around divided by how many architects are missing.

If you have a huge army of firefighters but zero architects, that new "Super-Score" goes through the roof. This tells the doctor, "This isn't just a small fire; the building is collapsing!"

4. The Results: Why This Matters

The study looked at over 1,000 patients. They found that these new "Architect-based" scores were just as good, and sometimes even better, at predicting:

• How blocked the arteries were (The Gensini Score).
• How hard the heart was struggling (Killip Class).
• Whether the patient had a massive heart attack (STEMI).

The "Aha!" Moment:
The new scores (SIII and SV) were able to spot the most dangerous patients just as accurately as the old, well-known scores, but they added a new layer of insight by tracking the "healing architects."

5. The Takeaway for the Real World

The Problem: Right now, if someone comes to the ER with chest pain, the most accurate way to see how bad their heart attack is involves a catheter (a tube put into the heart) or an angiogram. This takes time and is invasive.

The Solution: This paper suggests that a simple, cheap, 5-minute blood test (which hospitals already do) can now tell doctors exactly how bad the situation is.

• If the "Architects" are missing and the "Firefighters" are everywhere, the doctor knows immediately: "This is a critical emergency. We need to act fast."

Summary in One Sentence

This study discovered that by counting how many "healing specialists" (Eosinophils) are missing from a patient's blood, doctors can use a new, simple math formula to instantly predict how severe a heart attack is, helping them save lives faster in the emergency room.

---

Note: This is a preprint, meaning it is new research that hasn't been fully reviewed by other scientists yet, so it's a promising clue rather than a final rulebook for doctors just yet.

Technical Summary

1. Problem Statement

Acute Coronary Syndrome (ACS) is a leading cause of global mortality. Rapid assessment of ACS severity in the emergency department is critical for timely intervention. While established inflammatory markers like the Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Systemic Inflammatory Response Index (SIRI) are known predictors, they rely solely on neutrophils, monocytes, and lymphocytes.

• The Gap: There is a lack of research utilizing eosinophils (Eos) and novel ratios derived from eosinophils to predict ACS severity, coronary stenosis, and cardiac dysfunction.
• The Need: Clinicians require non-invasive, rapid, and cost-effective tools (beyond invasive angiography) to stratify risk immediately upon patient admission.

2. Methodology

• Study Design: Retrospective cohort study.
• Population:
  • Initial Cohort: 1,773 hospitalized ACS patients who underwent primary Percutaneous Coronary Intervention (PCI) at Yanbian University Hospital (China) between Jan 2016 and Dec 2018.
  • Final Cohort: 1,053 patients after exclusions (83 old MI, 567 other comorbidities like infection/autoimmune/allergies, 70 missing data).
  • Inclusion Criteria: Admission within 24 hours of symptom onset; completion of revascularization.
• Data Collection:
  • Preoperative venous blood samples for Complete Blood Count (CBC).
  • Calculation of inflammatory cell counts: Neutrophils (Neu), Lymphocytes (Lym), Monocytes (Mon), and Eosinophils (Eos).
  • Novel Ratios Calculated:
    • Standard: NLR (Neu/Lym), MLR (Mon/Lym), SIRI (Neu×Mon/Lym).
    • Eos-derived: NER (Neu/Eos), MER (Mon/Eos), SIII (Neu×Mon/Eos), NEL (Neu/Eos×Lym), MEL (Mon/Eos×Lym), SV (Neu×Mon/Eos×Lym).
• Severity Metrics:
  • Diagnosis: ECG classification (UA, NSTE-ACS, STEMI).
  • Anatomical Severity: Gensini Score (categorized into Low, Medium, High risk based on stenosis severity and location).
  • Functional Severity: Killip Classification (I to IV) for heart failure.
• Statistical Analysis:
  • Descriptive statistics (quartiles for skewed data).
  • Non-parametric intergroup comparisons.
  • Receiver Operating Characteristic (ROC) curve analysis to determine sensitivity, specificity, and Area Under the Curve (AUC) for predictive validity.

3. Key Contributions

• Novel Biomarkers: The study introduces and validates six new eosinophil-derived ratios, specifically highlighting SIII (Neu×Mon/Eos) and SV (Neu×Mon/Eos×Lym).
• Eosinophil Dynamics: It provides clinical evidence that peripheral eosinophil counts decrease as ACS severity, coronary stenosis, and cardiac dysfunction increase, contrasting with the increase seen in neutrophils and monocytes.
• Comparative Efficacy: It demonstrates that eosinophil-based ratios perform comparably to, and in some aspects offer novel insights alongside, established markers like NLR, MLR, and SIRI.

4. Key Results

• Eosinophil Counts:
  • Eosinophil levels were significantly lower in severe groups (STEMI, High Gensini Score, Killip Class I vs. controls).
  • Median Eos levels: STEMI (0.06) < NSTE-ACS (0.08) < Unstable Angina (0.12).
  • A significant decrease was observed correlating with higher Gensini scores and worsening Killip classes.
• Ratio Analysis:
  • All eosinophil-derived ratios (NER, MER, SIII, NEL, MEL, SV) were significantly elevated in severe ACS groups compared to controls.
  • SIII and SV showed the highest medians in the STEMI and High Gensini groups.
• Predictive Performance (ROC Analysis):
  • SIII and SV demonstrated high sensitivity and specificity for predicting STEMI, High Gensini scores, and Killip Class I.
  • AUC Values for STEMI Prediction:
    • NLR: 0.838
    • SIRI: 0.864
    • SIII: 0.815 (Cutoff: 22.5; Sensitivity: 0.759; Specificity: 0.746)
    • SV: 0.812 (Cutoff: 8.6; Sensitivity: 0.795; Specificity: 0.69)
  • The study concludes that SIII and SV are comparable to SIRI and NLR in diagnostic accuracy.
• Cardiac Function: While standard ratios (NLR, MLR, SIRI) did not show significant differences between Killip classes I, II, and III/IV, SIII and SV were significantly higher in Killip Class I compared to controls, suggesting early detection value for cardiac dysfunction.

5. Significance and Clinical Implications

• Emergency Triage: Since CBC is a routine, rapid, and low-cost test, incorporating eosinophil-derived ratios (SIII, SV) offers a powerful tool for emergency physicians to quickly stratify ACS risk without waiting for invasive angiography.
• Pathophysiological Insight: The findings suggest that the depletion of peripheral eosinophils during acute ischemia may be due to extensive thrombosis (eosinophils infiltrating the thrombus) or stress-induced cortisol release, rather than just a lack of production. This depletion correlates with a loss of anti-inflammatory protection (e.g., reduced IL-4, IL-10), leading to worse outcomes.
• Future Directions: The study proposes that combining eosinophil metrics with traditional leukocyte ratios provides a more comprehensive view of the "myeloid-lymphoid-eosinophil" imbalance, potentially offering superior risk stratification for Major Adverse Cardiac Events (MACE).

Limitations Noted: Single-center retrospective design, lack of long-term follow-up data, and potential unadjusted confounding factors (e.g., BMI, specific medications). Multicenter validation is required.